Works matching DE "DASATINIB"

Results: 792

A novel analytical method for Dasatinib Tablet by liquid chromatography in the presence of Triton X-100 and biorelevant media in dissolution medium.

Published in:

Journal of Research in Pharmacy, 2025, v. 29, n. 4, p. 1664, doi. 10.12991/jrespharm.1734636

By:

OZBAY, Tolga;
GURBETOGLU, Gulistan Pelin;
SARRACOGLU, Nagehan;
AYBEY DOGANAY, Asuman;
PINARBASLI, Onur

Publication type:

Article

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Published in:

Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 199, doi. 10.1007/s11060-018-2791-y

By:

Robison, Nathan J.;
Yeo, Kee Kiat;
Berliner, Adrian P.;
Malvar, Jemily;
Sheard, Michael A.;
Margol, Ashley S.;
Seeger, Robert C.;
Rushing, Teresa;
Finlay, Jonathan L.;
Sposto, Richard;
Dhall, Girish

Publication type:

Article

Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Published in:

Cardiovascular Drugs & Therapy, 2022, v. 36, n. 4, p. 589, doi. 10.1007/s10557-021-07169-z

By:

Yi, Jae-Sung;
Perla, Sravan;
Huang, Yan;
Mizuno, Kana;
Giordano, Frank J.;
Vinks, Alexander A.;
Bennett, Anton M.

Publication type:

Article

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Published in:

Pathology & Oncology Research, 2024, p. 1, doi. 10.3389/pore.2024.1611497

By:

Batar, Peter;
Alizadeh, Hussain;
Rokszin, Gyorgy;
Abonyi-Toth, Zsolt;
Demeter, Judit

Publication type:

Article

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.

Published in:

Pathology & Oncology Research, 2024, p. 1, doi. 10.3389/pore.2024.1611497

By:

Batar, Peter;
Alizadeh, Hussain;
Rokszin, Gyorgy;
Abonyi-Toth, Zsolt;
Demeter, Judit

Publication type:

Article

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6247, doi. 10.1007/s00432-022-04562-5

By:

Atallah, Ehab;
Mauro, Michael J.;
Hochhaus, Andreas;
Boquimpani, Carla;
Minami, Yosuke;
Maheshwari, Vikalp Kumar;
Saini, Lovneet;
Corbin, Regina;
Réa, Delphine

Publication type:

Article

Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 11, p. 2263, doi. 10.1007/s00432-016-2229-x

By:

Mahendrarajah, Nisintha;
Paulus, Ramin;
Krämer, Oliver

Publication type:

Article

New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells.

Published in:

Molecules, 2022, v. 27, n. 3, p. 750, doi. 10.3390/molecules27030750

By:

Oliveira, Andressa;
Moura, Stefany;
Pimentel, Luiz;
Neto, João;
Dantas, Rafael;
Silva-Jr, Floriano;
Bastos, Monica;
Boechat, Nubia

Publication type:

Article

The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.

Published in:

Molecules, 2021, v. 26, n. 9, p. 2547, doi. 10.3390/molecules26092547

By:

Woźniak, Marta;
Makuch, Sebastian;
Pastuch-Gawołek, Gabriela;
Wiśniewski, Jerzy;
Szeja, Wiesław;
Nowak, Martyna;
Krawczyk, Monika;
Agrawal, Siddarth;
Minutolo, Filippo

Publication type:

Article

Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors.

Published in:

Molecules, 2021, v. 26, n. 3, p. 691, doi. 10.3390/molecules26030691

By:

Bhujbal, Swapnil P.;
Keretsu, Seketoulie;
Cho, Seung Joo;
Toropova, Alla P.;
Kupka, Teobald

Publication type:

Article

Coumarin Derivatives in Inflammatory Bowel Disease.

Published in:

Molecules, 2021, v. 26, n. 2, p. 422, doi. 10.3390/molecules26020422

By:

Di Stasi, Luiz C.;
Matos, Maria João

Publication type:

Article

Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors.

Published in:

Molecules, 2020, v. 25, n. 21, p. 5154, doi. 10.3390/molecules25215154

By:

Kim, Hyo Jeong;
Ryu, Hwani;
Song, Jie-Young;
Hwang, Sang-Gu;
Jalde, Shivakumar S.;
Choi, Hyun-Kyung;
Ahn, Jiyeon

Publication type:

Article

Phenylpyrazalopyrimidines as Tyrosine Kinase Inhibitors: Synthesis, Antiproliferative Activity, and Molecular Simulations.

Published in:

Molecules, 2020, v. 25, n. 9, p. 2135, doi. 10.3390/molecules25092135

By:

Chhikara, Bhupender S.;
Ashraf, Sajda;
Mozaffari, Saghar;
St. Jeans, Nicole;
Mandal, Dindyal;
Tiwari, Rakesh Kumar;
Ul-Haq, Zaheer;
Parang, Keykavous;
Chen, Qiao-Hong

Publication type:

Article

Introduction of Mercaptoethyl at Sorafenib Pyridine-2-Amide Motif as a Potentially Effective Chain to Further get Sorafenib-PEG-DGL.

Published in:

Molecules, 2020, v. 25, n. 3, p. 573, doi. 10.3390/molecules25030573

By:

Wang, Ke;
Kuerbana, Kudelaidi;
Wan, Qi;
Yu, Zhihui;
Ye, Li;
Chen, Ying

Publication type:

Article

Trypanocidal Activity of Flavanone Derivatives.

Published in:

Molecules, 2020, v. 25, n. 2, p. 397, doi. 10.3390/molecules25020397

By:

Maciel Diogo, Gabriela;
Andrade, Josimara Souza;
Sales Junior, Policarpo Ademar;
Maria Fonseca Murta, Silvane;
Dos Santos, Viviane Martins Rebello;
Taylor, Jason Guy

Publication type:

Article

Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors.

Published in:

Molecules, 2019, v. 24, n. 19, p. 3543, doi. 10.3390/molecules24193543

By:

Kalinichenko, Elena;
Faryna, Aliaksandr;
Kondrateva, Viktoria;
Vlasova, Alena;
Shevchenko, Valentina;
Melnik, Alla;
Avdoshko, Olga;
Belko, Alla

Publication type:

Article

Antibacterial Evaluation, In Silico Characters and Molecular Docking of Schiff Bases Derived from 5-aminopyrazoles.

Published in:

Molecules, 2019, v. 24, n. 17, p. 3130, doi. 10.3390/molecules24173130

By:

Hassan, Ashraf S.;
Askar, Ahmed A.;
Nossier, Eman S.;
Naglah, Ahmed M.;
Moustafa, Gaber O.;
Al-Omar, Mohamed A.

Publication type:

Article

The Effects of Dasatinib in Experimental Acute Respiratory Distress Syndrome Depend on Dose and Etiology.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2015, v. 36, n. 4, p. 1644, doi. 10.1159/000430325

By:

Oliveira, Gisele P.;
Silva, Johnatas D.;
Marques, Patricia S.;
Gonçalves-de-albuquerque, Cassiano F.;
Santos, Heloísa L.;
Vascocellos, ana Paula;
Takiya, Christina M.;
Morales, Marcelo M.;
Pelosi, Paolo;
Mócsai, attila;
de Castro-Faria-Neto, Hugo C.;
Rocco, Patricia R.M.

Publication type:

Article

A boosted unbiased molecular dynamics method for predicting ligands binding mechanisms: probing the binding pathway of dasatinib to Src-kinase.

Published in:

Bioinformatics, 2020, v. 36, n. 18, p. 4714, doi. 10.1093/bioinformatics/btaa565

By:

Sohraby, Farzin;
Moghadam, Mostafa Javaheri;
Aliyar, Masoud;
Aryapour, Hassan

Publication type:

Article

Kronik Miyeloid Lösemi Hastaları’nda miR-21, miR-150, miR-155 Ekspresyon Düzeylerinin Araştırılması.

Published in:

Ahi Evran Medical Journal, 2025, v. 9, n. 1, p. 74, doi. 10.46332/aemj.1327364

By:

AVCILAR, Hüseyin;
ALTIN, Hatice;
ŞİMŞEK, Sevil;
KAYNAR, Leylagül

Publication type:

Article

Lycorine attenuated proliferation and induced apoptosis on imatinib-resistant K562 cell by inhibiting autophagy.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01080-3

By:

Bai, Jun;
Feng, Zuxi;
Chen, Yaqiong;
Li, Yanhong;
Zhang, Liansheng;
Li, Lijuan

Publication type:

Article

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report.

Published in:

2019

By:

Toya, Takumi;
Nagatomo, Yuji;
Kagami, Kazuki;
Adachi, Takeshi

Publication type:

Case Study

The Case of the Safety Session.

Published in:

2019

By:

Christensen, Deborah

Publication type:

Case Study

Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.

Published in:

2022

By:

Schoenbeck, Kelly L;
Atallah, Ehab;
Lin, Li;
Weinfurt, Kevin P;
Cortes, Jorge;
Deininger, Michael W N;
Kota, Vamsi;
Larson, Richard A;
Mauro, Michael J;
Oehler, Vivian G;
Pinilla-Ibarz, Javier;
Radich, Jerald P;
Schiffer, Charles A;
Shah, Neil P;
Silver, Richard T;
Thompson, James E;
Flynn, Kathryn E

Publication type:

journal article

Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1 Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells.

Published in:

2022

By:

Zhang, Yuexian;
Chen, Heng;
Shen, Yunfeng;
Zhou, Xin

Publication type:

journal article

Custo-efetividade do dasatinibe versus nilotinibe no tratamento de segunda linha da leucemia mieloide crônica (LMC) na perspectiva do Sistema Privado de Saúde do Brasil.

Published in:

JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2014, v. 6, n. 3, p. 111

By:

Araujo, Rafael;
de Nardi Chagas, Kélem;
Nabeshima, Camila;
Pepe, Camila;
Bernardino, Graziela;
Donato, Bonnie

Publication type:

Article

A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug–drug interactions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1144, doi. 10.1002/psp4.13146

By:

Kovar, Christina;
Loer, Helena Leonie Hanae;
Rüdesheim, Simeon;
Fuhr, Laura Maria;
Marok, Fatima Zahra;
Selzer, Dominik;
Schwab, Matthias;
Lehr, Thorsten

Publication type:

Article

The Hippo/YAP signaling pathway: the driver of cancer metastasis.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 7, p. 483, doi. 10.20892/j.issn.2095-3941.2023.0164

By:

Tianxing Zhou;
Xueyang Li;
Jing Liu;
Jihui Hao

Publication type:

Article

Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.

Published in:

Scientific Reports, 2014, p. 1, doi. 10.1038/srep06527

By:

Yifeng Sun;
Chang Chen;
Peng Zhang;
Huikang Xie;
Likun Hou;
Zheng Hui;
Yongjie Xu;
Qiaoling Du;
Xiao Zhou;
Bo Su;
Wen Gao

Publication type:

Article

Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting system.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-024-00741-x

By:

Zhao, Dehua;
Long, Xiaoqing;
Wang, Jisheng

Publication type:

Article

Metabolomic Profiling and Bioanalysis of Chronic Myeloid Leukemia: Identifying Biomarkers for Treatment Response and Disease Monitoring.

Published in:

Metabolites (2218-1989), 2025, v. 15, n. 6, p. 376, doi. 10.3390/metabo15060376

By:

Sayın, Selim;
Yıldırım, Murat;
Erdoğdu, Batuhan;
Kaplan, Ozan;
Koç, Emine;
Bulduk, Tuba;
Cömert, Melda;
Güney, Mustafa;
Çelebier, Mustafa;
Aylı, Meltem

Publication type:

Article

Brain Temperature as an Indicator of Cognitive Function in Traumatic Brain Injury Patients.

Published in:

Metabolites (2218-1989), 2024, v. 14, n. 1, p. 17, doi. 10.3390/metabo14010017

By:

Kitagawa, Maho;
Abiko, Kagari;
Sheriff, Sulaiman;
Maudsley, Andrew A.;
Li, Xinnan;
Sawamura, Daisuke;
Ahn, Sinyeob;
Tha, Khin Khin

Publication type:

Article

Urine Metabolomic Signature of People Diagnosed with Balkan Endemic Nephropathy and Other Types of Chronic Kidney Disease Compared with Healthy Subjects in Romania.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 5, p. 609, doi. 10.3390/metabo13050609

By:

Ordodi, Valentin L.;
Hădărugă, Nicoleta G.;
Hădărugă, Daniel I.;
Lukinich-Gruia, Alexandra T.;
Mărgineanu, Mihaela;
Tatu, Călin A.;
Păunescu, Virgil

Publication type:

Article

Profiling of Metabolic Differences between Hematopoietic Stem Cells and Acute/Chronic Myeloid Leukemia.

Published in:

Metabolites (2218-1989), 2020, v. 10, n. 11, p. 427, doi. 10.3390/metabo10110427

By:

Song, Byung Hoo;
Son, Su Young;
Kim, Hyun Kyu;
Ha, Tae Won;
Im, Jeong Suk;
Ryu, Aeli;
Jeon, Hyeji;
Chung, Hee Yong;
Oh, Jae Sang;
Lee, Choong Hwan;
Lee, Man Ryul

Publication type:

Article

IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia.

Published in:

Life (2075-1729), 2023, v. 13, n. 2, p. 259, doi. 10.3390/life13020259

By:

Cambria, Daniela;
Longhitano, Lucia;
La Spina, Enrico;
Giallongo, Sebastiano;
Orlando, Laura;
Giuffrida, Rosario;
Tibullo, Daniele;
Fontana, Paolo;
Barbagallo, Ignazio;
Nicoletti, Vincenzo Giuseppe;
Volti, Giovanni Li;
Fabro, Vittorio Del;
Coda, Anna Rita Daniela;
Liso, Arcangelo;
Palumbo, Giuseppe Alberto

Publication type:

Article

Plasma and intracellular concentrations in an elderly patient with chronic myeloid leukemia receiving low‐dose dasatinib therapy.

Published in:

2018

By:

Imamura, Masahiro;
Nakamura, Yusuke;
Sugawara, Mitsuru

Publication type:

Case Study

Efficacy of intermittently administered dasatinib with a reduced dose in an elderly patient with chronic myeloid leukemia.

Published in:

Geriatrics & Gerontology International, 2016, v. 16, n. 6, p. 768, doi. 10.1111/ggi.12604

By:

Imamura, Masahiro

Publication type:

Article

Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1113462

By:

Fang Cheng;
Qiling Xu;
Qiang Li;
Zheng Cui;
Weiming Li;
Fang Zeng

Publication type:

Article

Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.952640

By:

Madejczyk, Anna Marta;
Canzian, Federico;
Góra-Tybor, Joanna;
Campa, Daniele;
Sacha, Tomasz;
Link-Lenczowska, Dorota;
Florek, Izabela;
Prejzner, Witold;
Całbecka, M.;
Rymko, M.;
Dudziński, M.;
Orzechowska, Magdalena Julita;
Jamroziak, Krzysztof

Publication type:

Article

PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.744984

By:

Galiger, Celimene;
Dahlhaus, Meike;
Vitek, Michael Peter;
Debatin, Klaus-Michael;
Beltinger, Christian

Publication type:

Article

Stromal Fibroblasts Counteract the Caveolin-1-Dependent Radiation Response of LNCaP Prostate Carcinoma Cells.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.802482

By:

Wittka, Alina;
Ketteler, Julia;
Borgards, Lars;
Maier, Patrick;
Herskind, Carsten;
Jendrossek, Verena;
Klein, Diana

Publication type:

Article

Commentary: Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1575090

By:

Xue, Jihao;
Xue, Cheng;
Yin, Qijia;
Chen, Ligang;
Wang, Ming

Publication type:

Article

Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth.

Published in:

Frontiers in Genetics, 2020, v. 11, p. N.PAG, doi. 10.3389/fgene.2020.01036

By:

Zeng, Ling;
Boggs, Drexell Hunter;
Xing, Chuan;
Zhang, Zhuo;
Anderson, Joshua C.;
Wajapeyee, Narendra;
Veale, Chris;
Bredel, Markus;
Shi, Lewis Z.;
Bonner, James A.;
Willey, Christopher D.;
Yang, Eddy S.

Publication type:

Article

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase.

Published in:

2015

By:

Hughes, T P;
Saglio, G;
Quintás-Cardama, A;
Mauro, M J;
Kim, D-W;
Lipton, J H;
Bradley-Garelik, M B;
Ukropec, J;
Hochhaus, A

Publication type:

Journal Article

Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.

Published in:

Leukemia (08876924), 2015, v. 29, n. 1, p. 230, doi. 10.1038/leu.2014.256

By:

Yeung, D T;
Moulton, D J;
Heatley, S L;
Nievergall, E;
Dang, P;
Braley, J;
Branford, S;
Moore, S;
Mullighan, C G;
Hughes, T P;
White, D L

Publication type:

Article

Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.

Published in:

Leukemia (08876924), 2014, v. 28, n. 1, p. 206, doi. 10.1038/leu.2013.221

By:

Wu, K-n;
Wang, Y-j;
He, Y;
Hu, Y-x;
Fu, H-r;
Sheng, L-x;
Wang, B-s;
Fu, S;
Huang, H

Publication type:

Article

Dasatinib: A Review in Chronic Myeloid Leukaemia and Ph+ Acute Lymphoblastic Leukaemia.

Published in:

Drugs, 2017, v. 77, n. 1, p. 85, doi. 10.1007/s40265-016-0677-x

By:

Keating, Gillian

Publication type:

Article

Cévní nežádoucí účinky u pacientů s chronickou myeloidní leukemií při terapii inhibitory tyrozinkináz v každodenní klinické praxi – analýza z databáze INFINITY.

Published in:

Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 1, p. 29

By:

Čičátková, P.;
Žáčková, D.;
Horňák, T.;
Klamová, H.;
Bělohlávková, P.;
Stejskal, L.;
Křístková, Z.;
Baranová, J.;
Kvetková, A.;
Semerád, L.;
Procházková, J.;
Mayer, J.

Publication type:

Article

Dasatinib causing Intracerebral Bleeding in a Patient with Chronic Myeloid Leukaemia.

Published in:

Journal of Clinical & Diagnostic Research, 2022, v. 16, n. 6, p. 1, doi. 10.7860/JCDR/2022/52524.16434

By:

RATHOD, SANTOSH GOVIND;
KHAN, AFAQ AHMAD;
GEELANI, SAJAD AHMED;
ROSHAN, RESHMA;
BHAT, JAVID RASOOL

Publication type:

Article

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy.

Published in:

Stem Cells International, 2015, p. 1, doi. 10.1155/2016/9601493

By:

Aggerholm-Pedersen, Ninna;
Demuth, Christina;
Safwat, Akmal;
Meldgaard, Peter;
Kassem, Moustapha;
Sandahl Sorensen, Boe

Publication type:

Article